We recently published a list of 10 Stocks Investors Dumped Fast. In this article, we are going to take a look at where ...

The startup, which is backed by the venture arms of Sanofi, Roche and Novartis, is using dual adeno-associated viruses to ...

Sarepta Therapeutics (NasdaqGS:SRPT) saw its share price rise by 19% over the past month, a move that notably outpaced the broader market's 1% increase for the week and the 13% gain over the year.

The findings support the clinical benefits of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) ...

Michele Johnson, partner with Latham & Watkins, is among the recipients of the The Recorder's 2025 Women Leaders in Tech Law, ...

Detailed price information for Avidity Biosciences Inc (RNA-Q) from The Globe and Mail including charting and trades.

Vineet Nair continues to innovate in biopharmaceutical facility design, ensuring compliance with stringent air quality ...

TD Cowen analyst Ritu Baral maintained a Buy rating on Insmed (INSM – Research Report) today and set a price target of $114.00. The company’s shares opened today at $88.64. Co ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...